Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 636,675 | 248,931 | 895,500 | 642,407 | 377,603 |
| Depreciation Amortization | 73,241 | 38,115 | 104,700 | 75,845 | 48,006 |
| Income taxes - deferred | -57,737 | -40,988 | -360,100 | -190,327 | -162,652 |
| Accounts receivable | -232,927 | -137,928 | -143,800 | -176,079 | -284,178 |
| Other Working Capital | -619,526 | -27,902 | 240,800 | 148,686 | -100,205 |
| Other Operating Activity | 525,605 | 275,673 | 748,800 | 594,985 | 565,914 |
| Operating Cash Flow | $325,331 | $355,901 | $1,485,900 | $1,095,517 | $444,488 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -205,242 | -89,682 | -534,900 | -414,062 | -126,765 |
| PPE Investments | -105,310 | -50,461 | -511,900 | -361,486 | -242,930 |
| Investing Cash Flow | $-310,552 | $-140,143 | $-1,046,800 | $-775,548 | $-369,695 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 57,000 | 57,000 | 5,100 | 5,085 | 0 |
| Debt Repayment | -19,925 | -12,861 | -45,700 | -14,503 | -13,863 |
| Common Stock Issued | 188,693 | 16,673 | -516,700 | -152,340 | -178,511 |
| Common Stock Repurchased | -31,437 | N/A | -143,200 | -46,954 | -45,013 |
| Financing Cash Flow | $194,331 | $60,812 | $-700,500 | $-208,712 | $-237,387 |
| Beginning Cash Position | 547,703 | 547,703 | 809,100 | 809,102 | 809,102 |
| End Cash Position | 756,813 | 824,273 | 547,700 | 920,359 | 646,508 |
| Net Cash Flow | $209,110 | $276,570 | $-261,400 | $111,257 | $-162,594 |
| Free Cash Flow | |||||
| Operating Cash Flow | 325,331 | 355,901 | 1,485,900 | 1,095,517 | 444,488 |
| Capital Expenditure | -105,310 | -50,461 | -511,900 | -361,486 | -242,930 |
| Free Cash Flow | 220,021 | 305,440 | 974,000 | 734,031 | 201,558 |